Abstract
The serotonergic (5-HT) system has been implicated in the etiopathogenesis of psychoses. Since the 5-HT transporter plays an important role in regulation of 5-HT transmission, its gene can be considered as a candidate for vulnerability to psychiatric disorders. Two polymorphic sites of the 5-HT transporter gene—5-HTTLPR, a VNTR in the 5′ regulatory region, and a VNTR in the second intron—were studied in a sample of 61 families with schizophrenia for transmission disequilibrium. Each family contained at least two siblings affected with schizophrenia or schizoaffective disorder (mainly schizophrenic). One hundred and thirty-nine affected offspring with parental information for genotyping, were available for analysis. No preferential transmission of either short or long alleles of the promoter polymorphism was observed. However, a transmission distortion was detected for alleles of the intronic VNTR polymorphism (χ2TDT max =14.33; P = 0.0002; corrected P value = 0.0003) resulting in more frequent than expected transmission of the 12 repeat allele. This finding adds additional evidence to the idea that the serotonergic system may be involved in development of psychoses.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lesch KP, Moessner R . Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 1998; 44: 179–192
Owens MJ, Nemeroff CB . The role of serotonin in the pathophysiology of depression: focus on the serotonin transporter Clin Chem 1994; 40: 288–295
Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK et al. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients Arch Gen Psychiatry 1993; 50: 624–635
Meltzer HZ . Clozapine and other atypical neuroleptics: efficacy, side effects, optimal utilization J Clin Psychiat 1994; 12: 38–42
Roth BL, Ciaranello RD, Meltzer HZ . Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors J Pharmacol Exp Ther 1992; 260: 1361–1365
Watling KJ, Beer MS, Stanston JA, Newberry NR . Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat Eur J Pharmacol 1990; 182: 465–472
Joyce JN, Shane A, Lexov N, Winokur A, Casanova MF, Kleinman JE . Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics Neuropsychopharmacology 1993; 8: 315–336
Naylor L, Dean B, Opeskin K, Pavey G, Hill C, Keks N et al. Changes in serotonin transporter in the hippocampus of subjects with schizophrenia identified using (3H) paroxetine J Neural Transm Gen Sect 1996; 103: 749–757
Hernandez I, Sokolov BP . Abnormal expression of serotonin transporter mRNA in the frontal and temporal cortex of schizophrenics Mol Psychiatry 1997; 2: 57–64
Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL et al. Organization of human serotonin transporter gene J Neural Transm Gen Sect 1994; 95: 157–164
Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U et al. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene J Neural Transm Gen Sect 1995; 102: 247–254
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996; 274: 1527–1531
Bonnet-Brilhault F, Laurent C, Thibaut F, Campion D, Chavand O, Samolyk D et al. Serotonin transporter gene polymorphism and schizophrenia: an association study Biol Psychiatry 1997; 42: 634–636
Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D . A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics Mol Psychiatry 1998; 3: 328–332
Mendes de Oliveira JR, Otto PA, Vallada H, Lauriano V, Elkis H, Lafer B et al. Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia Am J Med Genet 1998; 81: 225–227
Rao D, Joensson EG, Paus S, Ganguli R, Noethen M, Nimgaonkar VL . Schizophrenia and the serotonin transporter gene Psychiatr Genet 1998; 8: 207–212
Stoeber G, Jatzke S, Heils A, Jungkunz G, Fuchs E, Knapp M et al. Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene Eur Arch Psychiatry Clin Neurosci 1998; 248: 82–86
Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwin GM et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression Lancet 1996; 347: 731–733
Stoeber G, Heils A, Lesch KP . Serotonin transporter gene polymorphism and affective disorder Lancet 1996; 347: 1340–1341
Collier DA, Arranz MJ, Sham P, Battersby S, Gill P, Aitchison KJ et al. A VNTR in the serotonin transporter gene is a potential susceptibility factor for bipolar affective disorder Neuroreport 1996; 7: 1675–1679
Rees M, Norton N, Jones I, McCndless F, Scourfield J, Holmans P et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT) Mol Psychiatry 1997; 2: 398–402
Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T et al. Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder Mol Psychiatry 1997; 2: 457–462
Collier DA, Stoeber G, Li T, Heils A, Catalano M, Di Bella D et al. A novel functional plymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders Mol Psychiatry 1996; 1: 453–460
Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders Am J Med Genet 1998; 81: 58–63
Ball D, Hill L, Freemann B, Eley TC, Strelau J, Reimann R et al. The serotonin transporter gene and peer-rated neuroticism Neuroreport 1997; 8: 1301–1304
Hoehe M, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Rosendahl D et al. Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders Am J Med Genet 1998; 81: 1–3
Jorm AF, Henderson AS, Jacomb PA, Christiansen H, Korten AE, Rodgers B et al. An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms Mol Psychiatry 1998; 3: 449–451
Esterling LE, Yoshikawa T, Turner G, Badner JA, Bengel D, Gershon ES et al. Serotonin transporter (5-HTT) gene and bipolar affective disorder Am J Med Genet 1998; 81: 37–40
Spielman RS, McGinnis RE, Ewens WJ . Transmission test for linkage disequilibrium: the insulin region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet 1993; 52: 506–516
Spielman RS, Ewens WJ . Invited Editorial: The TDT and other family-based tests for linkage disequilibrium and association Am J Hum Genet 1996; 59: 983–989
Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Hoenig S et al. Support for a locus on chromosome 18p conferring susceptibility to functional psychosis in families with schizophrenia by association and linkage analysis Am J Hum Genet 1998; 63: 1139–1152
Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene Proc Natl Acad Sci USA 1994; 91: 5918–5921
Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C et al. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect Am J Hum Genet 1995; 57: 1384–1394
Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K et al. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis Am J Med Genet 1998; 81: 302–307
Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B et al. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millenium Consortium Am J Med Genet 1998; 81: 290–295
Straub RE, MacLean CJ, Martin RB, Ma Y, Myakishev MV, Harris-Kerr C et al. A schizophrenia locus may be located in region 10p15–p11 Am J Med Genet 1998; 81: 296–301
Rice JP, Goate A, Williams JT, Bierut L, Dorr D, Wu W et al. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10 and 12 Am J Med Genet 1997; 74: 247–253
Levinson DF, Coon H . Chromosome 22 workshop Psychiatric Genet 1998; 8: 115–120
Bennet ST, Lucassen AM, Gough SCL et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin mini-satellite locus Nature Genet 1995; 9: 284–292
Abel L, Müller-Mysok B . Maximum-likelihood expression of the transmission/disequilibrium test and power considerations Am J Hum Genet 1998; 63: 664–667
Spitzer RL, Williams JB . Structured Clinical Interview for DSM-III Diagnoses—Personality Disorders New York State Psychiatric Institute: New York 1985
McGuffin P, Farmer A, Harvey I . A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system Arch Gen Psychiatry 1991; 48: 764–770
Morris AP, Curnow RN, Whittaker JC . Randomization tests of disease-marker associations Ann Hum Genet 1997; 61: 49–60
Acknowledgements
We wish to express our gratitude to all patients and their family members—without their cooperation this work would not have been possible. The work has been supported by grants of the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 400 (to MA, MK, WM, DBW). The scientific visit of DH was supported by a grant from Ministry of Science and Technology of the Republic of Croatia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hranilovic, D., Schwab, S., Jernej, B. et al. Serotonin transporter gene and schizophrenia: evidence for association/linkage disequilibrium in families with affected siblings. Mol Psychiatry 5, 91–95 (2000). https://doi.org/10.1038/sj.mp.4000599
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000599
Keywords
This article is cited by
-
Risk factors for suicide attempt: A population-based -genetic study from Telangana, India
Current Psychology (2021)
-
Simultaneous genotyping of multiple polymorphisms in human serotonin transporter gene and detection of novel allelic variants
Translational Psychiatry (2011)
-
Molecular Genetics of Monoamine Transporters: Relevance to Brain Disorders
Neurochemical Research (2008)
-
Serotonin transporter gene (5-HTTLPR) and major psychoses
Molecular Psychiatry (2002)
-
Molecular genetics of schizophrenia: past, present and future
Journal of Biosciences (2002)